Bioavailability and Pharmacokinetics
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Nxera PharmaHTL0018318
TevaLBR-101 IV
Clinical Trials (2)
Total enrollment: 36 patients across 2 trials
Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules
Start: Oct 2016Est. completion: Jan 2017
Phase 1Completed
Safety and Bioavailability of IV and SC LBR-101
Start: Oct 2013Est. completion: Jan 201536 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space